Home  »  Companies   »  Looking Closely at the Growth Curve for Hims &...

Looking Closely at the Growth Curve for Hims & Hers Health Inc. (HIMS)

Hims & Hers Health Inc. (NYSE:HIMS) went down by -2.94% from its latest closing price compared to the recent 1-year high of $7.97. The company’s stock price has collected 2.25% of gains in the last five trading sessions.

Is It Worth Investing in Hims & Hers Health Inc. (NYSE :HIMS) Right Now?

Plus, the 36-month beta value for HIMS is at 0.50. Opinions of the stock are interesting as 4 analysts out of 9 who provided ratings for Hims & Hers Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.”

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


The average price from analysts is $8.00, which is $1.14 above the current price. HIMS currently public float of 155.83M and currently shorts hold a 10.37% ratio of that float. Today, the average trading volume of HIMS was 1.72M shares.

HIMS’s Market Performance

HIMS stocks went up by 2.25% for the week, with a monthly jump of 8.52% and a quarterly performance of 77.51%, while its annual performance rate touched 49.69%. The volatility ratio for the week stands at 5.12% while the volatility levels for the past 30 days are set at 4.93% for Hims & Hers Health Inc. The simple moving average for the period of the last 20 days is 8.21% for HIMS stocks with a simple moving average of 33.70% for the last 200 days.

Analysts’ Opinion of HIMS

Many brokerage firms have already submitted their reports for HIMS stocks, with SVB Leerink repeating the rating for HIMS by listing it as a “Outperform.” The predicted price for HIMS in the upcoming period, according to SVB Leerink is $5 based on the research report published on November 08th of the previous year 2022.

BofA Securities, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $8.50, previously predicting the price at $7.50. The rating they have provided for HIMS stocks is “Buy” according to the report published on November 08th, 2022.

Piper Sandler gave a rating of “Neutral” to HIMS, setting the target price at $6 in the report published on October 17th of the previous year.

HIMS Trading at 12.21% from the 50-Day Moving Average

After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.91% of loss for the given period.

Volatility was left at 4.93%, however, over the last 30 days, the volatility rate increased by 5.12%, as shares surge +9.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +57.14% upper at present.

During the last 5 trading sessions, HIMS rose by +2.25%, which changed the moving average for the period of 200-days by +31.76% in comparison to the 20-day moving average, which settled at $6.74. In addition, Hims & Hers Health Inc. saw 13.26% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HIMS starting from Boughton Soleil, who sale 2,000 shares at the price of $7.51 back on Jan 17. After this action, Boughton Soleil now owns 287,089 shares of Hims & Hers Health Inc., valued at $15,020 using the latest closing price.

Boughton Soleil, the Chief Legal Officer of Hims & Hers Health Inc., sale 12,345 shares at $6.50 during a trade that took place back on Jan 03, which means that Boughton Soleil is holding 289,089 shares at $80,242 based on the most recent closing price.

Stock Fundamentals for HIMS

Current profitability levels for the company are sitting at:

  • -42.31 for the present operating margin
  • +73.72 for the gross margin

The net margin for Hims & Hers Health Inc. stands at -39.60. Equity return is now at value -26.60, with -22.00 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.